# Project Roadmap - Next Steps According to Project Outline

## Current Status Assessment

### ✅ **COMPLETED (Phase 1 & Partial Phase 3)**
1. ✅ Data Acquisition & Integration (Phase 1) - Complete
   - GWAS data downloaded (Bakker 2020)
   - Blood RNA-seq (GSE159610)
   - Tissue RNA-seq (GSE122897, GSE158558, GSE66238)
   - GTEx reference data

2. ✅ Differential Expression Analysis
   - GSE122897 ruptured vs unruptured analysis
   - Top genes identified and annotated
   - Pathway enrichment completed

3. ✅ Gene Annotation & Mapping
   - Top 10 genes annotated with symbols, names, IDs
   - Literature search template created

4. ✅ Basic Integration
   - GWAS integration (basic mapping)
   - Blood-tissue integration (started)
   - Pathway analysis

---

## 🎯 **NEXT STEPS ACCORDING TO PROJECT OUTLINE**

### **Phase 2: Polygenic Risk Score Development** ⚠️ **CRITICAL - NOT STARTED**

**Status:** ❌ **NOT DONE** - This is a critical component of the project outline

**Required Tasks:**
1. **Build Weighted PRS from 17 GWAS Loci**
   - Extract 17 risk variants from Bakker 2020 GWAS
   - Calculate PRS = sum(dosage × log(OR)) for each variant
   - Standardize PRS scores
   - **Output:** PRS scores for each patient/sample

2. **Develop Elastic Net PRS (Advanced)**
   - Use all SNPs from GWAS (not just 17 loci)
   - Train elastic net model
   - **Output:** Advanced PRS with better prediction

3. **Stratify Patients by Genetic Risk**
   - Low/Intermediate/High risk groups
   - Validate stratification
   - **Output:** Risk-stratified patient groups

**Expected Output:** PRS scores, validation AUC 0.75-0.80

**Scripts Needed:**
- `build_polygenic_risk_score.py` - Main PRS builder
- `validate_prs_performance.py` - PRS validation

---

### **Phase 3: Blood Transcriptomics Integration** ⚠️ **PARTIALLY DONE**

**Status:** 🟡 **IN PROGRESS** - Basic integration done, need completion

**Remaining Tasks:**
1. **Complete Rupture-Associated Gene Signature**
   - Identify 20-30 gene signature from blood RNA-seq
   - Cross-validate signature performance
   - **Output:** Validated blood signature (AUC 0.82-0.86)

2. **Harmonize Multiple Blood Datasets**
   - Integrate GSE159610 with other blood datasets if available
   - Batch correction and normalization

**Expected Output:** 20-30 gene signature, validation AUC 0.82-0.86

---

### **Phase 4: Endothelial Dysfunction Profiling** ⚠️ **NOT DONE**

**Status:** ❌ **NOT DONE** - Single-cell data not available, need alternative

**Required Tasks:**
1. **Cell-Type Deconvolution (Alternative to scRNA-seq)**
   - Use CIBERSORT, xCell, or similar tools
   - Estimate endothelial cell proportions from bulk RNA-seq
   - Analyze endothelial-specific signatures

2. **Identify EC-Specific Dysfunction Markers**
   - ANGPT2, ICAM1, VCAM1, THBS1, PERP
   - Compare expression in aneurysm vs control
   - Calculate EC dysfunction score

**Expected Output:** EC dysfunction score, top 5 dysregulated genes

**Scripts Needed:**
- `endothelial_dysfunction_analysis.py` - EC analysis with deconvolution
- `calculate_ec_dysfunction_score.py` - EC score calculation

---

### **Phase 5: Multi-Omics Integration** ⚠️ **CRITICAL - NOT DONE**

**Status:** ❌ **NOT DONE** - This is the core innovation of the project

**Required Tasks:**
1. **Combine All Data Layers**
   - PRS (genetic) - **NEED TO BUILD FIRST**
   - Blood RNA signature (GSE159610) - **PARTIALLY DONE**
   - Tissue transcriptomics (rupture datasets) - **DONE**
   - EC dysfunction markers - **NEED TO BUILD**
   - Clinical factors (if available)

2. **Build Integrated Prediction Model**
   - Gradient boosting classifier
   - Train on combined features
   - Cross-validation
   - **Output:** Integrated model with AUC 0.85-0.92

3. **SHAP Interpretation**
   - Explain which factors drive predictions
   - Feature importance analysis
   - **Output:** SHAP values and interpretations

4. **Risk Stratification**
   - Low/Intermediate/High risk categories
   - Clinical decision thresholds
   - **Output:** Risk-stratified predictions

**Expected Output:** Integrated model with AUC 0.85-0.92

**Scripts Needed:**
- `multi_omics_integration.py` - Main integration script
- `build_integrated_model.py` - Model training
- `shap_interpretation.py` - SHAP analysis
- `risk_stratification.py` - Risk categorization

---

### **Phase 6: Exosomal Biomarker Discovery** ⚠️ **NOT DONE**

**Status:** ❌ **NOT DONE** - Optional but valuable

**Required Tasks:**
1. **Identify Novel Exosomal ncRNAs**
   - Analyze non-coding RNAs in blood data
   - Identify rupture-associated ncRNAs
   - Validate candidates

2. **Create Clinical Nomogram**
   - Combine integrated score + exosomal biomarkers
   - Create nomogram for clinical use
   - **Output:** Clinical nomogram

**Expected Output:** 10 novel biomarkers, nomogram

---

### **Phase 7-8: Validation & Manuscript** ⚠️ **NOT DONE**

**Status:** ❌ **NOT DONE** - Final phase

**Required Tasks:**
1. **Comparison with PHASES Score**
   - Calculate PHASES scores (if clinical data available)
   - Compare AUC: Integrated model vs PHASES
   - Demonstrate 20-30% improvement

2. **Generate Publication-Quality Figures**
   - ROC curves
   - Feature importance plots
   - Pathway networks
   - Risk stratification plots

3. **Write Manuscript**
   - Methods section
   - Results section
   - Discussion

**Expected Output:** Publication-ready manuscript

---

## 🚨 **CRITICAL PATH - IMMEDIATE NEXT STEPS**

### **Priority 1: Build Polygenic Risk Score (Phase 2)**
**Why Critical:** PRS is required for multi-omics integration (Phase 5)

**Action Items:**
1. Create `build_polygenic_risk_score.py`
   - Load Bakker 2020 GWAS summary statistics
   - Extract 17 risk loci
   - Calculate weighted PRS
   - Validate performance

2. Map PRS to samples
   - Need to match GWAS variants to sample genotypes
   - If genotypes not available, use population-level PRS

**Timeline:** 1-2 days

---

### **Priority 2: Complete Blood Integration (Phase 3)**
**Why Critical:** Blood signature needed for multi-omics model

**Action Items:**
1. Complete blood signature identification
   - Finalize 20-30 gene signature
   - Cross-validate performance
   - Calculate blood RNA score

**Timeline:** 1 day

---

### **Priority 3: Endothelial Dysfunction Analysis (Phase 4)**
**Why Critical:** EC dysfunction is third omics layer for integration

**Action Items:**
1. Implement cell-type deconvolution
   - Use CIBERSORTx or xCell
   - Estimate EC proportions
   - Extract EC-specific expression

2. Calculate EC dysfunction score
   - Analyze ANGPT2, ICAM1, VCAM1, etc.
   - Create dysfunction score

**Timeline:** 2-3 days

---

### **Priority 4: Multi-Omics Integration (Phase 5)**
**Why Critical:** This is the core innovation - combining all layers

**Action Items:**
1. Prepare integrated feature matrix
   - PRS scores
   - Blood RNA signature scores
   - EC dysfunction scores
   - Clinical factors (if available)

2. Train gradient boosting model
   - Cross-validation
   - Hyperparameter tuning
   - Model evaluation

3. SHAP interpretation
   - Feature importance
   - Prediction explanations

4. Risk stratification
   - Low/Intermediate/High risk
   - Clinical thresholds

**Timeline:** 3-4 days

---

## 📋 **RECOMMENDED EXECUTION ORDER**

### **Week 1: Foundation**
1. ✅ Build Polygenic Risk Score (Phase 2)
2. ✅ Complete Blood Integration (Phase 3)
3. ✅ Endothelial Dysfunction Analysis (Phase 4)

### **Week 2: Integration**
4. ✅ Multi-Omics Integration (Phase 5)
5. ✅ Model Training & Validation
6. ✅ SHAP Interpretation

### **Week 3: Refinement**
7. ✅ Exosomal Biomarker Discovery (Phase 6) - Optional
8. ✅ PHASES Score Comparison
9. ✅ Risk Stratification

### **Week 4: Manuscript**
10. ✅ Generate Figures
11. ✅ Write Manuscript
12. ✅ Final Validation

---

## 🎯 **SUCCESS CRITERIA**

According to project outline, we need:

1. ✅ **PRS Development:** AUC 0.75-0.80
2. ✅ **Blood Signature:** AUC 0.82-0.86
3. ✅ **Integrated Model:** AUC 0.85-0.92
4. ✅ **Improvement over PHASES:** 20-30% better
5. ✅ **EC Dysfunction Score:** Top 5 genes identified
6. ✅ **Risk Stratification:** Low/Intermediate/High categories

---

## 📝 **SUMMARY**

**What's Done:**
- ✅ Data acquisition
- ✅ Differential expression analysis
- ✅ Gene annotation
- ✅ Basic integrations

**What's Missing (Critical):**
- ❌ Polygenic Risk Score (Phase 2)
- ❌ Complete Blood Integration (Phase 3)
- ❌ Endothelial Dysfunction Analysis (Phase 4)
- ❌ Multi-Omics Integration (Phase 5) - **CORE INNOVATION**
- ❌ Model Training & Validation
- ❌ PHASES Comparison

**Next Immediate Step:** Build Polygenic Risk Score (Phase 2)

---

**Last Updated:** Based on project outline review  
**Status:** Following project outline phases 1-8






